The interplay between neuroinflammation and endothelial dysfunction in cerebral small vessel disease
- 1Department of Neurology, The First Hospital of Jilin University
Abstract
Cerebral small vessel disease (CSVD) is a leading cause of ischemic stroke and vascular cognitive impairment. Despite well-defined neuroimaging features and a substantial clinical burden, the underlying pathological mechanisms of CSVD remain poorly understood, and effective interventions are still lacking. Current human and experimental evidence suggest that endothelial dysfunction and neuroinflammation are closely coupled and may form a mutually reinforcing process in many CSVD-relevant settings. This review synthesizes available evidence into a working framework in which vascular risk factors promote endothelial phenotypic switching and blood-brain barrier (BBB) dysfunction, thereby facilitating neuroinflammatory activation. Pericytes, astrocytes, and microglia within the neurovascular unit can then amplify barrier injury and inflammatory signaling through context-dependent feedback interactions, including matrix metalloproteinase-mediated proteolysis. In turn, the chronic inflammatory milieu may sustain persistent endothelial dysfunction or alter endothelial responsiveness to subsequent inflammatory stimuli, potentially allowing pathological processes to continue even after the original triggers are attenuated. Based on this evidence-guided framework, we also evaluate therapeutic strategies directed at distinct nodes of the endothelial dysfunction-neuroinflammation network.
Related
- Exploring immune-endothelial interactions in neuroinflammation and vascular dysfunction.
- Immune-endothelial crosstalk at the nexus of neuroinflammation and vascular dysfunction in aging
- INPP5D/SHIP1 in Alzheimer's Disease: Linking Microglial Substrate Handling to Neuroinflammation and Neurovascular Dysfunction.
- Phytochemical Modulation of Oxidative Stress-Inflammation Coupling in Cardiovascular Disease: From Nrf2 and NADPH Oxidases to NLRP3 and Endothelial Dysfunction.
- CO067 | ELUCIDATING THE EVIL RELATIONSHIP OF METABOLIC DYSFUNCTION–ASSOCIATED FATTY LIVER DISEASE WITH CARDIOVASCULAR COMORBIDITIES: THE COMPLEX INTERPLAY AMONG HYPERCOAGULABILITY, INFLAMMATION, AND LIVER FIBROSIS
BibTeX
@article{jin2026interplay,
title = {{The interplay between neuroinflammation and endothelial dysfunction in cerebral small vessel disease}},
author = {Cong Jin and Yin Zhao},
journal = {Frontiers in Immunology},
year = {2026},
month = may,
doi = {10.3389/fimmu.2026.1809556},
url = {https://doi.org/10.3389/fimmu.2026.1809556},
note = {CC BY},
}
RIS
TY - JOUR
TI - The interplay between neuroinflammation and endothelial dysfunction in cerebral small vessel disease
AU - Cong Jin
AU - Yin Zhao
PY - 2026
DA - 2026/05/21
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1809556
UR - https://doi.org/10.3389/fimmu.2026.1809556
AB - Cerebral small vessel disease (CSVD) is a leading cause of ischemic stroke and vascular cognitive impairment. Despite well-defined neuroimaging features and a substantial clinical burden, the underlying pathological mechanisms of CSVD remain poorly understood, and effective interventions are still lacking. Current human and experimental evidence suggest that endothelial dysfunction and neuroinflammation are closely coupled and may form a mutually reinforcing process in many CSVD-relevant settings. This review synthesizes available evidence into a working framework in which vascular risk factors promote endothelial phenotypic switching and blood-brain barrier (BBB) dysfunction, thereby facilitating neuroinflammatory activation. Pericytes, astrocytes, and microglia within the neurovascular unit can then amplify barrier injury and inflammatory signaling through context-dependent feedback interactions, including matrix metalloproteinase-mediated proteolysis. In turn, the chronic inflammatory milieu may sustain persistent endothelial dysfunction or alter endothelial responsiveness to subsequent inflammatory stimuli, potentially allowing pathological processes to continue even after the original triggers are attenuated. Based on this evidence-guided framework, we also evaluate therapeutic strategies directed at distinct nodes of the endothelial dysfunction-neuroinflammation network.
SN - 1664-3224
ER -